You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

thalidomide

Showing 76 - 100 of 663
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Nsclc Trial in Jinan (Thalidomide, pemetrexed, cisplatin)

Unknown status
  • Advanced Nsclc
  • Thalidomide
  • +3 more
  • Jinan, Shandong, China
    Qilu hospital of Shandong University
Jun 3, 2019

Neuropathy;Peripheral Trial in Houston (Abbott® DRG / Abbott®/Medtronic® SCS, Control Group)

Recruiting
  • Neuropathy;Peripheral
  • Abbott® DRG / Abbott®/Medtronic® SCS
  • Control Group
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

Bioequivalence Study Trial in Chennai (Pomalidomide 4 MG Oral Capsule)

Not yet recruiting
  • Bioequivalence Study
  • Pomalidomide 4 MG Oral Capsule
  • Chennai, Tamil Nadu, India
    Azidus Laboratories
Sep 22, 2023

Multiple Myeloma Trial in Italy, Switzerland (Nelfinavir, Lenalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Milano, Italy
  • +10 more
Jul 4, 2022

Multiple Myeloma and Plasma Cell Tumor Trial in Phoenix, Duarte (biological, drug, procedure)

Completed
Has Results
  • Multiple Myeloma and Plasma Cell Neoplasm
  • filgrastim
  • +7 more
  • Phoenix, Arizona
  • +1 more
Jun 24, 2019

Multiple Myeloma Trial in Hackensack (Bortezomib)

Terminated
Has Results
  • Multiple Myeloma
  • Hackensack, New Jersey
    The Cancer Center at Hackensack University Medical Center
Jun 24, 2022

Myeloma Trial in Houston (Thalidomide, Lenalidomide, Questionnaires)

Terminated
Has Results
  • Myeloma
  • Thalidomide
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 3, 2019

Multiple Myeloma Trial in Belgium, France (Thalidomide)

Completed
  • Multiple Myeloma
  • Thalidomide
  • Gilly, Belgium
  • +48 more
Oct 16, 2019

Multiple Myeloma Trial in Lanzhou (Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Lanzhou, Gansu, China
    The First Hospital of Lanzhou University
Jul 9, 2022

Thrombosis in Multiple Myeloma in an University Medical Center

Recruiting
  • Multiple Myeloma
  • +2 more
  • Multiple myeloma
  • Groningen, Netherlands
    University Medical Center Groningen
Sep 12, 2022

High Grade Squamous Intra-epithelial Lesion (HSIL) Trial in Darlinghurst (Pomalidomide 2 MG Oral Capsule [Pomalyst])

Active, not recruiting
  • High Grade Squamous Intra-epithelial Lesion (HSIL)
  • Pomalidomide 2 MG Oral Capsule [Pomalyst]
  • Darlinghurst, New South Wales, Australia
    St Vincent's Hospital
Mar 28, 2022

CIPN and it's Impact on Quality of Life in Patients Receiving

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy
    • (no location specified)
    Apr 24, 2023

    Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Chicago, Rochester, Cleveland (Venetoclax, Umbralisib, Ublituximab)

    Terminated
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Chicago, Illinois
    • +2 more
    Aug 19, 2022

    Multiple Myeloma, Relapse Multiple Myeloma, Refractory Multiple Myeloma Trial in Shenzhen (BCMA CAR-T cells)

    Recruiting
    • Multiple Myeloma
    • +2 more
    • BCMA CAR-T cells
    • Shenzhen, Guangdong, China
      Li Yu
    Dec 7, 2021

    Multiple Myeloma Trial in United States (Ruxolitinib Oral Tablet [Jakafi], Lenalidomide, Methylprednisolone)

    Recruiting
    • Multiple Myeloma
    • Ruxolitinib Oral Tablet [Jakafi]
    • +2 more
    • Alhambra, California
    • +12 more
    Apr 18, 2022

    Multiple Myeloma and Plasma Cell Tumor Trial in Canada, United States (prednisone, thalidomide)

    Completed
    • Multiple Myeloma and Plasma Cell Neoplasm
    • Duluth, Minnesota
    • +63 more
    Mar 31, 2020

    Dermatomyositis Trial in Nanchang (Lenalidomide)

    Not yet recruiting
    • Dermatomyositis
    • Nanchang, Jiangxi, China
      Department of Rheumatology and Clinical Immunology, Jiangxi Prov
    Aug 3, 2022

    Myelodysplastic Syndrome Trial in France, Germany, Spain (Lenalidomide, Placebo)

    Active, not recruiting
    • Myelodysplastic Syndrome
    • Strasbourg, Bajo Rin, France
    • +24 more
    Nov 22, 2021

    Cancer, Therapy-Related Trial (Chemotherapy drugs, thalidomide and megestrol acetate, optimal support treatment)

    Unknown status
    • Cancer, Therapy-Related
    • Chemotherapy drugs
    • +2 more
    • (no location specified)
    Dec 12, 2018

    Mantle Cell Lymphoma Trial in Tianjin (Etoposide, Doxorubicin, Dexamethasone)

    Unknown status
    • Mantle Cell Lymphoma
    • Tianjin, China
      Shuhua Yi
    Jun 13, 2019

    Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

    Not yet recruiting
    • Newly Diagnosed Multiple Myeloma
    • Hamburg, Germany
    • +3 more
    Dec 16, 2022

    Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)

    Not yet recruiting
    • Malignant Pleural Mesothelioma
    • Cairo, Egypt
      Ain Shams University Hospital
    Dec 20, 2022

    Oral Ulcer Trial in Beijing (Lenalidomide 10 mg)

    Not yet recruiting
    • Oral Ulcer
    • Lenalidomide 10 mg
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jul 5, 2022

    Amyloidosis Trial in Athens (Lenalidomide, Dexamethasone and Cyclophosphamide)

    Completed
    • Amyloidosis
    • Lenalidomide, Dexamethasone and Cyclophosphamide
    • Athens, Attica, Greece
      Alexandra Hospital , Department of Clinical Therapeutics
    Apr 27, 2021

    Psoriasis Trial in Winston-Salem (Otezla - Standard Care, Reminder Text Intervention with apremilast, Extended Consultation for

    Not yet recruiting
    • Psoriasis
    • Otezla - Standard Care
    • +2 more
    • Winston-Salem, North Carolina
      Wake Forest University Health Sciences
    Jan 31, 2023